Roflumilast Tablet
Product Images NDC 72205-201

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 72205-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Roflumilast-250mcg-10s-blister-foil-label (Roflumilast 250mcg 10s Blister Foil Label)

The generated text appears to be a combination of product names, company names, and manufacturing information. It is not possible to generate a useful description from it.*

FDA Label Image

Roflumilast-250mcg-14s-blister-foil-label (Roflumilast 250mcg 14s Blister Foil Label)

This is a description of a medication called Roflumilast Tablet manufactured by Novadoz Pharmaceuticals in India. The medication is associated with a lot number and an expiration date. The text includes some unclear characters and repetitive mentions of the product name without any additional information.*

FDA Label Image

Roflumilast-250mcg-20s-blister-carton-label (Roflumilast 250mcg 20s Blister Carton Label)

Roflumilast Tablets with NDC 72205-201-24 are supplied with 250 mcg of roflumilast each and packaged in 20 unit-dose tablets. The usual dosage is one tablet (250 mcg) by mouth once a day for the first 28 days. The medication guide should be given to each patient. The tablets should be stored at 20°-25°C (68°C-77°F) and excursions permitted to 15°-30°C (59°-86°F). For full prescribing information, refer to the package insert. The tablets are distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Roflumilast-250mcg-28s-blister-carton-label (Roflumilast 250mcg 28s Blister Carton Label)

Roflumilast Tablets are a prescription medication available in a package of 28 tablets from Novadoz. Each tablet contains 250mg of Roflumilast. The recommended dosage for adults is one tablet, taken orally once a day, for the first 28 days. The medication guide should be given to each patient. The tablets should be stored at 20°C to 25°C (68°F to 77°F). The medication should not be removed from the blister package until immediately prior to administration. The tablets are manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Roflumilast-500mcg-10s-blister-foil-label (Roflumilast 500mcg 10s Blister Foil Label)

Roflumilast Tablet is a medicinal drug produced by Novadoz Pharmaceuticals LLC in India. The National Drug Code (NDC) for the medicine is 7220520011. There is another NDC number i.e., 72205-200-41 associated with the medicine as well. The tablet is issued on 082022 and is available in the percentage strengths of 25 and 5.*

FDA Label Image

Roflumilast-500mcg-30s-cntr-label (Roflumilast 500mcg 30s Cntr Label)

This text describes a medication that comes in tablet form and is meant to be taken once daily by mouth, with a recommended dosage for adults of one tablet containing 500 meg. The medication was manufactured by MSN Laboratories Private Limited and is distributed by Novadoz Pharmaceuticals LLC, with contact information being provided for the latter. The medication guide should be dispensed to each patient, and the medication should be stored in a specific temperature range. This medication should be kept out of the reach of children.*

FDA Label Image

Roflumilast-500mcg-90s-cntr-label (Roflumilast 500mcg 90s Cntr Label)

This is a prescription medicine with the National Drug Code 72205-200-90. The recommended daily dose for adults is one tablet of 500 mcg to be taken orally. It is advised not to let the medicine be reached by children and to be stored at optimal temperatures of 20°C - 25°C (68°-77°F). This medicine is manufactured by MSN Laboratories Private Limited, Hyderabad, Telangana, 509 228, INDIA, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714, USA. For more information, it is recommended to refer to the package insert provided with the medicine.*

FDA Label Image

Roflumilast-500mcg-blister-carton-label (Roflumilast 500mcg Blister Carton Label)

Roflumilast Tablets is a medication to be dispensed only on the prescription of a certified medical practitioner. It is available in a pack of 100 tablets with each containing 500mcg/500mg of Roflumilast as per the manufacture information. Patients should be provided with the medication guide when dispensing pack, kept in a cool environment ranging from 20°C to 25°C, and protected from children reach. The manufacturer of the drug is MSN Laboratories Private Limited based in India, while the distribution is by Novadoz Pharmaceuticals LLC of Piscataway, New Jersey. No other useful information is available due to low quality.*

FDA Label Image

Roflumilast-fig1 (Roflumilast Fig1)

This is a list of medications and their respective effects with other drugs. The drugs Cimetidine, Enoxacin, Fluvoxamine, Ketoconazole, Minulet, and Erythromycin have cautionary advice when used in conjunction with other medications, while Budesonide, Digoxin, Formoterol, Maalox, Midazolam, Montelukast, salbutamol, Sildena, Theophylline, and Warfarin do not require dose adjustment. Rifampicin is not recommended, and there is information about Roflumilast and Roflumilast N-oxide.*

FDA Label Image

Roflumilast-structure (Roflumilast Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.